Stock GUTS FRACTYL HEALTH, INC.
Add to a list
To use this feature you must be a member
Log inSign up

All News Fractyl Health, Inc.

Equities

GUTS

US35168W1036

Real-time Estimate Cboe BZX
Other stock markets
 12:21:04 27/06/2024 am IST 		5-day change 1st Jan Change
4.43 USD +2.31% Intraday chart for Fractyl Health, Inc. -17.72% 0.00%
24/06 Fractyl Health, Inc. Announces Advancement in Weight Maintenance Pipeline and Business Updates CI
24/06 Fractyl Health Says Potential Diabetes, Obesity Treatment Performed Well in Preclinical Trial MT

All News

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Fractyl Health to Present at Piper Sandler 2nd Annual Virtual Obesity Day
GL
Fractyl Health Announces Advancement in Weight Maintenance Pipeline and Business Updates
GL
Fractyl Health, Inc. Announces Advancement in Weight Maintenance Pipeline and Business Updates
CI
Fractyl Health Says Potential Diabetes, Obesity Treatment Performed Well in Preclinical Trial
MT
Fractyl Health Presents New Preclinical Data on Sustained Weight Maintenance and Improved Body Composition from its Rejuva® Single-Administration GLP-1 Pancreatic Gene Therapy in President’s Select Oral Presentation at the American Diabetes Association’s 84th Scientific Sessions
AQ
Fractyl Health, Inc. Presents New Preclinical Data on Sustained Weight Maintenance and Improved Body Composition from its Rejuva® Single-Administration GLP-1 Pancreatic Gene Therapy at the American Diabetes Association?s 84th Scientific Sessions
CI
Fractyl Health Presents New Preclinical Data on Sustained Weight Maintenance and Improved Body Composition from its Rejuva® Single-Administration GLP-1 Pancreatic Gene Therapy in President’s Select Oral Presentation at the American Diabetes Association’s 84th Scientific Sessions
GL
Fractyl Health to Present New Preclinical Obesity Data from Rejuva® Platform at the American Diabetes Association’s 84th Scientific Sessions
GL
Fractyl Health Presents Compelling Preclinical Data from Single-Administration GLP-1 Pancreatic Gene Therapy Rejuva® at Digestive Disease Week 2024
GL
Fractyl Health, Inc. Presents Compelling Preclinical Data from Single-Administration GLP-1 Pancreatic Gene Therapy Rejuva At Digestive Disease Week 2024
CI
Earnings Flash (GUTS) FRACTYL HEALTH Reports Q1 Revenue $33,000
MT
Fractyl Health Reports First Quarter 2024 Financial Results and Provides Business Updates
GL
Fractyl Health, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Fractyl Health Says New Revita Data Show Sustained Weight Loss, Glucose Control in Type 2 Diabetes
MT
Fractyl Health Presents Clinical Update on Revita® German Real-World Registry for Patients With Advanced Type 2 Diabetes (T2D)
GL
Fractyl Health Presents Clinical Update on Revita German Real-World Registry for Patients With Advanced Type 2 Diabetes
CI
Fractyl Health to Present at BofA Securities 2024 Health Care Conference
GL
Fractyl Health to Report First Quarter 2024 Financial Results and Provide Business Updates on May 13, 2024
GL
Fractyl Health Announces Multiple Presentations at the Upcoming Digestive Disease Week (DDW) 2024 Conference and the German Diabetes Association (DDG) Annual Meeting
GL
Fractyl Health Names Adrian Kimber Chief Commercial Officer; Shares Down
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. GUTS Stock
  4. News Fractyl Health, Inc.